Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

Crittenden DB, Lehmann RA, Schneck L, Keenan RT, Shah B, Greenberg JD, Cronstein BN, Sedlis SP, Pillinger MH.

J Rheumatol. 2012 Jul;39(7):1458-64. doi: 10.3899/jrheum.111533. Epub 2012 Jun 1.

PMID:
22660810
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Serum urate levels and gout flares: analysis from managed care data.

Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW.

J Clin Rheumatol. 2006 Apr;12(2):61-5.

PMID:
16601538
[PubMed - indexed for MEDLINE]
3.

Opportunities for improving medication use and monitoring in gout.

Singh JA, Hodges JS, Asch SM.

Ann Rheum Dis. 2009 Aug;68(8):1265-70. doi: 10.1136/ard.2008.092619. Epub 2008 Aug 13.

PMID:
18701554
[PubMed - indexed for MEDLINE]
4.

Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.

Chohan S, Becker MA, MacDonald PA, Chefo S, Jackson RL.

Arthritis Care Res (Hoboken). 2012 Feb;64(2):256-61. doi: 10.1002/acr.20680.

PMID:
22052584
[PubMed - indexed for MEDLINE]
5.

Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.

Kim SC, Schmidt BM, Franklin JM, Liu J, Solomon DH, Schneeweiss S.

Arthritis Care Res (Hoboken). 2013 Dec;65(12):2008-14. doi: 10.1002/acr.22067.

PMID:
23861232
[PubMed - indexed for MEDLINE]
6.

Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved.

Thiele RG, Schlesinger N.

Rheumatol Int. 2010 Feb;30(4):495-503. doi: 10.1007/s00296-009-1002-8. Epub 2009 Jun 20.

PMID:
19543895
[PubMed - indexed for MEDLINE]
7.

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.

PMID:
18331118
[PubMed - indexed for MEDLINE]
Free Article
8.

Quality of care for gout in the US needs improvement.

Singh JA, Hodges JS, Toscano JP, Asch SM.

Arthritis Rheum. 2007 Jun 15;57(5):822-9.

PMID:
17530682
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset.

Jackson G, Wright C, Thornley S, Taylor WJ, Te Karu L, Gow PJ, Arroll B, Gribben B, Dalbeth N, Winnard D.

Rheumatology (Oxford). 2012 Oct;51(10):1820-4. Epub 2012 Jun 20.

PMID:
22723595
[PubMed - indexed for MEDLINE]
10.

Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.

Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR.

Curr Med Res Opin. 2009 Jul;25(7):1711-9. doi: 10.1185/03007990903017966.

PMID:
19485724
[PubMed - indexed for MEDLINE]
11.

Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.

Schumacher HR Jr, Evans RR, Saag KG, Clower J, Jennings W, Weinstein SP, Yancopoulos GD, Wang J, Terkeltaub R.

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1462-70. doi: 10.1002/acr.21690.

PMID:
22549879
[PubMed - indexed for MEDLINE]
12.

Allopurinol and mortality in hyperuricaemic patients.

Luk AJ, Levin GP, Moore EE, Zhou XH, Kestenbaum BR, Choi HK.

Rheumatology (Oxford). 2009 Jul;48(7):804-6. doi: 10.1093/rheumatology/kep069. Epub 2009 May 15.

PMID:
19447769
[PubMed - indexed for MEDLINE]
Free Article
13.

Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.

Taylor TH, Mecchella JN, Larson RJ, Kerin KD, Mackenzie TA.

Am J Med. 2012 Nov;125(11):1126-1134.e7. doi: 10.1016/j.amjmed.2012.05.025.

PMID:
23098865
[PubMed - indexed for MEDLINE]
14.

Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout.

Khanna PP, Perez-Ruiz F, Maranian P, Khanna D.

Rheumatology (Oxford). 2011 Apr;50(4):740-5. doi: 10.1093/rheumatology/keq346. Epub 2010 Dec 8.

PMID:
21147824
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The management of gout at an academic healthcare center in Beijing: a physician survey.

Fang W, Zeng X, Li M, Chen LX, Schumacher HR Jr, Zhang F.

J Rheumatol. 2006 Oct;33(10):2041-9.

PMID:
17014019
[PubMed - indexed for MEDLINE]
16.

Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.

Richette P, Brière C, Hoenen-Clavert V, Loeuille D, Bardin T.

J Rheumatol. 2007 Oct;34(10):2093-8. Epub 2007 Sep 15.

PMID:
17896799
[PubMed - indexed for MEDLINE]
17.

[Diagnosis and treatment of gout: not always simple].

van Vugt RM, Jacobs JW, Bijlsma JW.

Ned Tijdschr Geneeskd. 1996 Jan 27;140(4):177-9. Dutch. No abstract available.

PMID:
8618639
[PubMed - indexed for MEDLINE]
18.

Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system.

Mikuls TR, Curtis JR, Allison JJ, Hicks RW, Saag KG.

J Rheumatol. 2006 Mar;33(3):562-6. Epub 2006 Feb 15.

PMID:
16482645
[PubMed - indexed for MEDLINE]
19.

Chronic kidney disease in gout in a managed care setting.

Fuldeore MJ, Riedel AA, Zarotsky V, Pandya BJ, Dabbous O, Krishnan E.

BMC Nephrol. 2011 Aug 3;12:36. doi: 10.1186/1471-2369-12-36.

PMID:
21812963
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.

Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G.

Rheumatology (Oxford). 2013 Jun;52(6):1126-31. doi: 10.1093/rheumatology/kes431. Epub 2013 Feb 7.

PMID:
23392592
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk